Cargando…

A review of fibrin and fibrin composites for bone tissue engineering

Tissue engineering has emerged as a new treatment approach for bone repair and regeneration seeking to address limitations associated with current therapies, such as autologous bone grafting. While many bone tissue engineering approaches have traditionally focused on synthetic materials (such as pol...

Descripción completa

Detalles Bibliográficos
Autores principales: Noori, Alireza, Ashrafi, Seyed Jamal, Vaez-Ghaemi, Roza, Hatamian-Zaremi, Ashraf, Webster, Thomas J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516781/
https://www.ncbi.nlm.nih.gov/pubmed/28761338
http://dx.doi.org/10.2147/IJN.S124671
_version_ 1783251226531463168
author Noori, Alireza
Ashrafi, Seyed Jamal
Vaez-Ghaemi, Roza
Hatamian-Zaremi, Ashraf
Webster, Thomas J
author_facet Noori, Alireza
Ashrafi, Seyed Jamal
Vaez-Ghaemi, Roza
Hatamian-Zaremi, Ashraf
Webster, Thomas J
author_sort Noori, Alireza
collection PubMed
description Tissue engineering has emerged as a new treatment approach for bone repair and regeneration seeking to address limitations associated with current therapies, such as autologous bone grafting. While many bone tissue engineering approaches have traditionally focused on synthetic materials (such as polymers or hydrogels), there has been a lot of excitement surrounding the use of natural materials due to their biologically inspired properties. Fibrin is a natural scaffold formed following tissue injury that initiates hemostasis and provides the initial matrix useful for cell adhesion, migration, proliferation, and differentiation. Fibrin has captured the interest of bone tissue engineers due to its excellent biocompatibility, controllable biodegradability, and ability to deliver cells and biomolecules. Fibrin is particularly appealing because its precursors, fibrinogen, and thrombin, which can be derived from the patient’s own blood, enable the fabrication of completely autologous scaffolds. In this article, we highlight the unique properties of fibrin as a scaffolding material to treat bone defects. Moreover, we emphasize its role in bone tissue engineering nanocomposites where approaches further emulate the natural nanostructured features of bone when using fibrin and other nanomaterials. We also review the preparation methods of fibrin glue and then discuss a wide range of fibrin applications in bone tissue engineering. These include the delivery of cells and/or biomolecules to a defect site, distributing cells, and/or growth factors throughout other pre-formed scaffolds and enhancing the physical as well as biological properties of other biomaterials. Thoughts on the future direction of fibrin research for bone tissue engineering are also presented. In the future, the development of fibrin precursors as recombinant proteins will solve problems associated with using multiple or single-donor fibrin glue, and the combination of nanomaterials that allow for the incorporation of biomolecules with fibrin will significantly improve the efficacy of fibrin for numerous bone tissue engineering applications.
format Online
Article
Text
id pubmed-5516781
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-55167812017-07-31 A review of fibrin and fibrin composites for bone tissue engineering Noori, Alireza Ashrafi, Seyed Jamal Vaez-Ghaemi, Roza Hatamian-Zaremi, Ashraf Webster, Thomas J Int J Nanomedicine Review Tissue engineering has emerged as a new treatment approach for bone repair and regeneration seeking to address limitations associated with current therapies, such as autologous bone grafting. While many bone tissue engineering approaches have traditionally focused on synthetic materials (such as polymers or hydrogels), there has been a lot of excitement surrounding the use of natural materials due to their biologically inspired properties. Fibrin is a natural scaffold formed following tissue injury that initiates hemostasis and provides the initial matrix useful for cell adhesion, migration, proliferation, and differentiation. Fibrin has captured the interest of bone tissue engineers due to its excellent biocompatibility, controllable biodegradability, and ability to deliver cells and biomolecules. Fibrin is particularly appealing because its precursors, fibrinogen, and thrombin, which can be derived from the patient’s own blood, enable the fabrication of completely autologous scaffolds. In this article, we highlight the unique properties of fibrin as a scaffolding material to treat bone defects. Moreover, we emphasize its role in bone tissue engineering nanocomposites where approaches further emulate the natural nanostructured features of bone when using fibrin and other nanomaterials. We also review the preparation methods of fibrin glue and then discuss a wide range of fibrin applications in bone tissue engineering. These include the delivery of cells and/or biomolecules to a defect site, distributing cells, and/or growth factors throughout other pre-formed scaffolds and enhancing the physical as well as biological properties of other biomaterials. Thoughts on the future direction of fibrin research for bone tissue engineering are also presented. In the future, the development of fibrin precursors as recombinant proteins will solve problems associated with using multiple or single-donor fibrin glue, and the combination of nanomaterials that allow for the incorporation of biomolecules with fibrin will significantly improve the efficacy of fibrin for numerous bone tissue engineering applications. Dove Medical Press 2017-07-12 /pmc/articles/PMC5516781/ /pubmed/28761338 http://dx.doi.org/10.2147/IJN.S124671 Text en © 2017 Noori et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Review
Noori, Alireza
Ashrafi, Seyed Jamal
Vaez-Ghaemi, Roza
Hatamian-Zaremi, Ashraf
Webster, Thomas J
A review of fibrin and fibrin composites for bone tissue engineering
title A review of fibrin and fibrin composites for bone tissue engineering
title_full A review of fibrin and fibrin composites for bone tissue engineering
title_fullStr A review of fibrin and fibrin composites for bone tissue engineering
title_full_unstemmed A review of fibrin and fibrin composites for bone tissue engineering
title_short A review of fibrin and fibrin composites for bone tissue engineering
title_sort review of fibrin and fibrin composites for bone tissue engineering
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516781/
https://www.ncbi.nlm.nih.gov/pubmed/28761338
http://dx.doi.org/10.2147/IJN.S124671
work_keys_str_mv AT noorialireza areviewoffibrinandfibrincompositesforbonetissueengineering
AT ashrafiseyedjamal areviewoffibrinandfibrincompositesforbonetissueengineering
AT vaezghaemiroza areviewoffibrinandfibrincompositesforbonetissueengineering
AT hatamianzaremiashraf areviewoffibrinandfibrincompositesforbonetissueengineering
AT websterthomasj areviewoffibrinandfibrincompositesforbonetissueengineering
AT noorialireza reviewoffibrinandfibrincompositesforbonetissueengineering
AT ashrafiseyedjamal reviewoffibrinandfibrincompositesforbonetissueengineering
AT vaezghaemiroza reviewoffibrinandfibrincompositesforbonetissueengineering
AT hatamianzaremiashraf reviewoffibrinandfibrincompositesforbonetissueengineering
AT websterthomasj reviewoffibrinandfibrincompositesforbonetissueengineering